Membranous nephropathy: the start of a paradigm shift, Curr Opin Nephrol Hypertens, vol.21, issue.2, pp.203-213, 2012. ,
Glomérulonéphrites extra-membraneuses in ,
Atlas de pathologie rénale, Médecine-Sciences Flammarion Paris, pp.165-180, 2008. ,
Membranous nephropathy: recent travels and new roads ahead, Kidney Int, vol.77, issue.9, pp.765-70, 2010. ,
Pathophysiological advances in membranous nephropathy: time for a shift in patient's care, Lancet, vol.385, issue.9981, pp.1983-92, 2015. ,
M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy, N Engl J Med, vol.361, issue.1, pp.11-21, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00417718
Apport de l'immunologie au diagnostic en néphrologie : actualités en 2012. Revue Francophone des Laboratoires, vol.444, pp.95-96, 2012. ,
Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy, N Engl J Med, vol.371, issue.24, pp.2277-87, 2014. ,
Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy, J Clin Invest, vol.126, issue.7, pp.2519-2551, 2016. ,
Antiphospholipase A2 receptor autoantibodies: a comparison of three different immunoassays for the diagnosis of idiopathic membranous nephropathy, J Immunol Res, p.143274, 2014. ,
Antiphospholipase A2 receptor autoantibody guided diagnosis and treatment of membranous nephropathy: a new personalized medical approach, Clin J Am Soc Nephrol, vol.9, issue.8, pp.1341-1344, 2014. ,
A Proposal for a Serology-Based Approach to Membranous Nephropathy, J Am Soc Nephrol, vol.28, issue.2, pp.421-430, 2017. ,
Anti-phospholipase A2 receptor antibodies and the pathogenesis of membranous nephropathy, Nephron Clin Pract, vol.128, issue.3-4, pp.232-239, 2014. ,
Mammalian phospholipase A2: phospholipase A2 receptor, Biol Pharm Bull, vol.27, issue.8, pp.1165-1172, 2004. ,
Membranous nephropathy: integrating basic science into improved clinical management, Kidney Int, vol.91, issue.3, pp.566-574, 2017. ,
Antiphospholipase A2 Receptor Autoantibodies: A Step Forward in the Management of Primary Membranous Nephropathy, Biomed Res Int, p.249740, 2015. ,
Association of phospholipase A2 receptor 1 polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan, J Biomed Sci, vol.17, p.81, 2010. ,
Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy, N Engl J Med, vol.364, issue.7, pp.616-642, 2011. ,
Anti-PLA 2R antibodies in membranous nephropathy: ready for routine clinical practice ?, Neth J Med, vol.70, issue.3, pp.109-122, 2012. ,
An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy, J Am Soc Nephrol, vol.28, issue.2, pp.520-531, 2017. ,
The diagnosis accuracy of PLA2R-AB in the diagnosis of idiopathic membranous nephropathy: a meta-analysis ,
Diagnostic accuracy of PLA2R autoantibodies and glomerular staining for the differentiation of idiopathic and secondary membranous nephropathy: an updated meta-analysis. Sci Rep, vol.5, p.8803, 2015. ,
Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy, Nephrol Dial Transplant, vol.28, issue.7, pp.1839-1883, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00919114
Renal phospholipase A2 receptor in hepatitis B virus-associated membranous nephropathy, Am J Nephrol, vol.41, issue.4-5, pp.345-53, 2015. ,
Prevalence of Enhanced Granular Expression of Thrombospondin Type-1 Domain-Containing 7A in the Glomeruli of Japanese Patients with Idiopathic Membranous Nephropathy, PLoS One, vol.10, issue.9, p.138841, 2015. ,
A Mechanism for Cancer-Associated Membranous Nephropathy, N Engl J Med, vol.374, issue.20, pp.1995-2001, 2016. ,
THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity, Mod Pathol, vol.29, issue.4, pp.421-427, 2016. ,
Coexistence of ANCAassociated glomerulonephritis and anti-phospholipase A(2) receptor antibody-positive membranous nephropathy, Clin Kidney J, vol.5, issue.2, pp.162-165, 2012. ,
Management of Membranous Nephropathy in Western Countries, vol.1, pp.126-163, 2015. ,
KDIGO Clinical Practice Guideline for Glomérulonephritis, Kidney Int Suppl, vol.2, pp.139-274, 2012. ,
The iceberg analogy of autoimmunity, Postgrad Med J, vol.48, issue.556, pp.95-102, 1972. ,
Serum anti-PLA2R antibodies may be present before clinical manifestations of membranous nephropathy, Kidney Int, vol.89, issue.6, p.1399, 2016. ,
Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy, J Am Soc Nephrol, vol.26, issue.2, pp.291-301, 2015. ,
Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy, J Am Soc Nephrol, vol.26, issue.2, pp.302-315, 2015. ,
Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy, J Am Soc Nephrol, vol.27, issue.5, pp.1517-1550, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01455661
Long-term outcomes of persistent disease and relapse in primary membranous nephropathy, Nephrol Dial Transplant, vol.31, issue.12, pp.2108-2114, 2016. ,
Association of anti-PLA2R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy, Clin J Am Soc Nephrol, vol.9, issue.8, pp.1386-92, 2014. ,
A new rescue regimen with plasma exchange and rituximab in high-risk membranous glomerulonephritis, Eur J Clin Invest, vol.45, issue.12, pp.1260-1269, 2015. ,